(Q41217607)

28 September 2017

title

Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach (English)

1 reference

28 September 2017

0 references

1 reference

Kohei Otake

1

1 reference

28 September 2017

Keiichi Uchida

2

1 reference

28 September 2017

Shozo Ide

3

1 reference

28 September 2017

Yuhko Kobayashi

4

1 reference

28 September 2017

Issei Kobayashi

5

1 reference

28 September 2017

Masato Kusunoki

6

1 reference

28 September 2017

publication date

15 October 2015

1 reference

28 September 2017

published in

Pediatric Blood & Cancer

1 reference

28 September 2017

volume

63

1 reference

28 September 2017

issue

2

1 reference

28 September 2017

page(s)

221-227

1 reference

Neuroblastoma: biological insights into a clinical enigma

28 September 2017

cites work

1 reference

21 January 2018

1 reference

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

21 January 2018

1 reference

Recent advances in neuroblastoma

21 January 2018

1 reference

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

21 January 2018

1 reference

International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

21 January 2018

1 reference

Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation

21 January 2018

1 reference

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma

21 January 2018

1 reference

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

21 January 2018

1 reference

Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer.

21 January 2018

1 reference

Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.

21 January 2018

1 reference

Cancer biomarkers: knowing the present and predicting the future

21 January 2018

1 reference

Quantitative multiple reaction monitoring analysis of synaptic proteins from human brain.

21 January 2018

1 reference

New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI.

21 January 2018

1 reference

IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples

21 January 2018

1 reference

Quantitative immunohistochemical analysis reveals association between sodium iodide symporter and estrogen receptor expression in breast cancer

21 January 2018

1 reference

Growth-regulated expression and G0-specific turnover of the mRNA that encodes URH49, a mammalian DExH/D box protein that is highly related to the mRNA export protein UAP56

21 January 2018

1 reference

DExD/H-box proteins and their partners: helping RNA helicases unwind

21 January 2018

1 reference

Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families.

21 January 2018

1 reference

DEAD-box proteins: the driving forces behind RNA metabolism

21 January 2018

1 reference

Requirement of DDX39 DEAD box RNA helicase for genome integrity and telomere protection

21 January 2018

1 reference

Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor.

21 January 2018

1 reference

Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.25778

1 reference

28 September 2017

1 reference